| Dr Heather M Rafal, DPM | |
|
1601 Milltown Rd Ste 24, Wilmington, DE 19808-4084 | |
| (302) 998-0178 | |
| Not Available |
| Full Name | Dr Heather M Rafal |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 19 Years |
| Location | 1601 Milltown Rd Ste 24, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023346335 | NPI | - | NPPES |
| E10000197 | Other | DE | LICENSE NUMBER |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital | Wilmington, DE | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foot Care Group, P.a. | 2062419161 | 3 |
News Archive
Abbott and Reata Pharmaceuticals today announced that they have entered into a collaboration agreement to develop and commercialize bardoxolone methyl (bardoxolone), which is currently in late Phase 2 trials for the treatment of chronic kidney disease (CKD).
Shenzhen Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced the formation of Beike Holdings Limited a joint venture with Bangkok-based SiriCell Technologies, Inc. Beike Holdings, which is headquartered in Bangkok, Thailand, will focus primarily on the establishment of new international subsidiaries and the development of collaborative hospital partnerships with Southeast Asia's leading healthcare providers.
The Global Program to Eliminate Lymphatic Filariasis delivers mass drug administration to 500 million people each year, and adverse events are common following treatment. Now, researchers have reported in PLOS Neglected Tropical Diseases that certain changes in gene expression are associated with these adverse events.
Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.
The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a study led by researchers at Linköping University in Sweden. The study, published in the scientific journal Gastroenterology, is the first to investigate IBS using living bacteria.
› Verified 9 days ago
| Provider Name | Foot Care Group, P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215922349 PECOS PAC ID: 2062419161 Enrollment ID: O20061102000607 |
News Archive
Abbott and Reata Pharmaceuticals today announced that they have entered into a collaboration agreement to develop and commercialize bardoxolone methyl (bardoxolone), which is currently in late Phase 2 trials for the treatment of chronic kidney disease (CKD).
Shenzhen Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced the formation of Beike Holdings Limited a joint venture with Bangkok-based SiriCell Technologies, Inc. Beike Holdings, which is headquartered in Bangkok, Thailand, will focus primarily on the establishment of new international subsidiaries and the development of collaborative hospital partnerships with Southeast Asia's leading healthcare providers.
The Global Program to Eliminate Lymphatic Filariasis delivers mass drug administration to 500 million people each year, and adverse events are common following treatment. Now, researchers have reported in PLOS Neglected Tropical Diseases that certain changes in gene expression are associated with these adverse events.
Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.
The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a study led by researchers at Linköping University in Sweden. The study, published in the scientific journal Gastroenterology, is the first to investigate IBS using living bacteria.
› Verified 9 days ago
| Provider Name | Christiana Care Health Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821302472 PECOS PAC ID: 9739097569 Enrollment ID: O20110610000296 |
News Archive
Abbott and Reata Pharmaceuticals today announced that they have entered into a collaboration agreement to develop and commercialize bardoxolone methyl (bardoxolone), which is currently in late Phase 2 trials for the treatment of chronic kidney disease (CKD).
Shenzhen Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced the formation of Beike Holdings Limited a joint venture with Bangkok-based SiriCell Technologies, Inc. Beike Holdings, which is headquartered in Bangkok, Thailand, will focus primarily on the establishment of new international subsidiaries and the development of collaborative hospital partnerships with Southeast Asia's leading healthcare providers.
The Global Program to Eliminate Lymphatic Filariasis delivers mass drug administration to 500 million people each year, and adverse events are common following treatment. Now, researchers have reported in PLOS Neglected Tropical Diseases that certain changes in gene expression are associated with these adverse events.
Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.
The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a study led by researchers at Linköping University in Sweden. The study, published in the scientific journal Gastroenterology, is the first to investigate IBS using living bacteria.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heather M Rafal, DPM 208 Nichols Ave, Wilmington, DE 19803-2589 Ph: (267) 475-5174 | Dr Heather M Rafal, DPM 1601 Milltown Rd Ste 24, Wilmington, DE 19808-4084 Ph: (302) 998-0178 |
News Archive
Abbott and Reata Pharmaceuticals today announced that they have entered into a collaboration agreement to develop and commercialize bardoxolone methyl (bardoxolone), which is currently in late Phase 2 trials for the treatment of chronic kidney disease (CKD).
Shenzhen Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced the formation of Beike Holdings Limited a joint venture with Bangkok-based SiriCell Technologies, Inc. Beike Holdings, which is headquartered in Bangkok, Thailand, will focus primarily on the establishment of new international subsidiaries and the development of collaborative hospital partnerships with Southeast Asia's leading healthcare providers.
The Global Program to Eliminate Lymphatic Filariasis delivers mass drug administration to 500 million people each year, and adverse events are common following treatment. Now, researchers have reported in PLOS Neglected Tropical Diseases that certain changes in gene expression are associated with these adverse events.
Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.
The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a study led by researchers at Linköping University in Sweden. The study, published in the scientific journal Gastroenterology, is the first to investigate IBS using living bacteria.
› Verified 9 days ago
Dr. Alexander Terris, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 2700 Silverside Rd Ste 3b, Wilmington, DE 19810 Phone: 302-478-1694 Fax: 302-478-1696 | |
Dr. Travis J Dwyer, D.P.M Podiatrist Medicare: Medicare Enrolled Practice Location: 1010 N Bancroft Pkwy, Suite 12, Wilmington, DE 19805 Phone: 302-658-1129 Fax: 302-658-7646 | |
Brian William Mcdermott, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1010 N Bancroft Pkwy, Ste 12, Wilmington, DE 19805 Phone: 302-658-1129 | |
First State Foot & Ankle, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 4512 Kirkwood Highway Suite 203, Wilmington, DE 19808 Phone: 302-984-0257 Fax: 302-984-0258 | |
Dr Lesly Robinson Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4011 N Market Street, Wilmington, DE 19802 Phone: 302-762-0200 Fax: 302-762-0500 | |
Foot Care Group, P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 1601 Milltown Rd, Suite 24, Wilmington, DE 19808 Phone: 302-998-0178 Fax: 302-999-0700 |